Plain-English translation of NCT05979675 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows patients newly diagnosed with acute myeloid leukemia (a serious blood cancer) at 20 hospitals across Turkey. Rather than testing a new medication or treatment, researchers simply want to track what happens to patients like you over time — what treatments doctors recommend, how you respond, and your health outcomes. The goal is to better understand how this disease is managed in real-world settings.
By collecting information from many patients across the country, doctors and researchers can see patterns in how acute myeloid leukemia is treated and which approaches work best. This knowledge helps improve future care for patients with this blood cancer.
You likely qualify if…
You likely don't qualify if…
You would continue your regular medical care at one of the participating hospitals in Turkey. During your routine visits, your doctors will track information about your diagnosis, treatments, and health status. You will be followed for 3 years after enrolling, with the entire study running for 5 years. There are no extra appointments or experimental treatments — just standard follow-up care, with researchers keeping careful records of your medical journey.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)
Enrollment target
~250 participants
Started
December 2021
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Volkan Karakus, Assoc. Prof.
Sentez Cro
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.